Patent Assignment
Reel/Frame 062133/0229
Change of Name
Recorded: 2022-12-14
Pages: 5
Assignor
CUREVAC AG
Executed: 2022-09-26
Assignee
CUREVAC SE
FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, 72076, GERMANY
Covered Properties
(5)
Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application:
14/994,913 →
Publication:
US 2016/0129105
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 18, 2004
From: MULBE, FLORIAN VON DER; HOERR, INGMAR; PASCOLO, STEVEN
To: CURE VAC GMBH
Reel/Frame 014979/0703 →
Change of Name
Nov 16, 2015
From: CUREVAC GMBH
To: CUREVAC AG
Reel/Frame 037115/0430 →
Assignment of Assignor's Interest
Dec 14, 2022
From: VON DER MÜLBE, FLORIAN; HOERR, INGMAR; PASCOLO, STEVE
To: CUREVAC GMBH
Reel/Frame 062096/0684 →
Change of Name
Dec 14, 2022
From: CUREVAC GMBH
To: CUREVAC AG
Reel/Frame 062230/0050 →